Serum Ustekinumab Concentrations Are Associated With Remission in Crohn’s Disease Defined by a Serum-Based Endoscopic Healing Index

por Walshe, Margaret, Borowski, Krzysztof, Battat, Robert, Hudesman, David, Wolf, Douglas C, Okada, Lauren, Jain, Anjali, Silverberg, Mark S
Publicado 2021

Adherence rates and health care costs in Crohn’s disease patients receiving certolizumab pegol with and without home health nurse assistance: results from a retrospective analysis...

por Wolf, Douglas C, Jaganathan, Srihari, Burudpakdee, Chakkarin, Seetasith, Arpamas, Low, Robert, Lee, Edward, Gucky, Jay, Yassine, Mohamed, Schwartz, David A
Publicado 2018

Clinical Benefit of Long-Term Adalimumab Treatment in Patients With Crohn’s Disease Following Loss of Response or Intolerance to Infliximab: 96-Week Efficacy Data From GAIN/ADHERE...

por Panaccione, Remo, Sandborn, William J, D’Haens, Geert, Wolf, Douglas C, Berg, Sofie, Maa, Jen-fue, Petersson, Joel, Robinson, Anne M
Publicado 2018

Therapeutic Drug Monitoring of Tumor Necrosis Factor Antagonists in Crohn Disease: A Theoretical Construct to Apply Pharmacokinetics and Guidelines to Clinical Practice

por Vande Casteele, Niels, Feagan, Brian G, Wolf, Douglas C, Pop, Anca, Yassine, Mohamed, Horst, Sara N, Ritter, Timothy E, Sandborn, William J
Publicado 2020

Practical Primer Addressing Real-World Use Scenarios of Subcutaneous Vedolizumab in Ulcerative Colitis and Crohn’s Disease: Post Hoc Analyses of VISIBLE Studies

por Sandborn, William J, Chen, Jingjing, Kisfalvi, Krisztina, Loftus, Edward V, D’Haens, Geert, Candela, Ninfa, Lasch, Karen, Wolf, Douglas C, Uddin, Sharif M, Danese, Silvio
Publicado 2023

Ozanimod as a novel oral small molecule therapy for the treatment of Crohn's disease: The YELLOWSTONE clinical trial program

por Feagan, Brian G., Schreiber, Stefan, Afzali, Anita, Rieder, Florian, Hyams, Jeffrey, Kollengode, Kanthi, Pearlman, Jared, Son, Vladimir, Marta, Cecilia, Wolf, Douglas C., D'Haens, Geert G.
Publicado 2022

A predictive data-driven framework for endocrine prioritization: a triazole fungicide case study

por Paul Friedman, Katie, Papineni, Sabitha, Marty, M. Sue, Yi, Kun Don, Goetz, Amber K., Rasoulpour, Reza J., Kwiatkowski, Pat, Wolf, Douglas C., Blacker, Ann M., Peffer, Richard C.
Publicado 2016

The codification of hazard and its impact on the hazard versus risk controversy

por Doe, John E., Boobis, Alan R., Cohen, Samuel M., Dellarco, Vicki L., Fenner-Crisp, Penelope A., Moretto, Angelo, Pastoor, Timothy P., Schoeny, Rita S., Seed, Jennifer G., Wolf, Douglas C.
Publicado 2021

A new approach to the classification of carcinogenicity

por Doe, John E., Boobis, Alan R., Cohen, Samuel M., Dellarco, Vicki L., Fenner-Crisp, Penelope A., Moretto, Angelo, Pastoor, Timothy P., Schoeny, Rita S., Seed, Jennifer G., Wolf, Douglas C.
Publicado 2022

Transforming the evaluation of agrochemicals

por Wolf, Douglas C, Bhuller, Yadvinder, Cope, Rhian, Corvaro, Marco, Currie, Richard A, Doe, John, Doi, Adriana, Hilton, Gina, Mehta, Jyotigna, Saltmiras, David, Sewell, Fiona, Trainer, Maria, Déglin, Sandrine E
Publicado 2022

Long-Term Efficacy and Safety of Ozanimod in Moderately to Severely Active Ulcerative Colitis: Results From the Open-Label Extension of the Randomized, Phase 2 TOUCHSTONE Study

por Sandborn, William J, Feagan, Brian G, Hanauer, Stephen, Vermeire, Severine, Ghosh, Subrata, Liu, Wenzhong J, Petersen, AnnKatrin, Charles, Lorna, Huang, Vivian, Usiskin, Keith, Wolf, Douglas C, D’Haens, Geert
Publicado 2021

Four-Year Maintenance Treatment With Adalimumab in Patients with Moderately to Severely Active Ulcerative Colitis: Data from ULTRA 1, 2, and 3

por Colombel, Jean-Frederic, Sandborn, William J, Ghosh, Subrata, Wolf, Douglas C, Panaccione, Remo, Feagan, Brian, Reinisch, Walter, Robinson, Anne M, Lazar, Andreas, Kron, Martina, Huang, Bidan, Skup, Martha, Thakkar, Roopal B
Publicado 2014

Illustrative case using the RISK21 roadmap and matrix: prioritization for evaluation of chemicals found in drinking water

por Wolf, Douglas C., Bachman, Ammie, Barrett, Gordon, Bellin, Cheryl, Goodman, Jay I., Jensen, Elke, Moretto, Angelo, McMullin, Tami, Pastoor, Timothy P., Schoeny, Rita, Slezak, Brian, Wend, Korinna, Embry, Michelle R.
Publicado 2016

Sustained Clinical Remission With Vedolizumab in Patients With Moderate-to-Severe Ulcerative Colitis

por Feagan, Brian G, Schreiber, Stefan, Wolf, Douglas C, Axler, Jeffrey L, Kaviya, Arpeat, James, Alexandra, Curtis, Rebecca I, Geransar, Parnia, Stallmach, Andreas, Ehehalt, Robert, Bokemeyer, Bernd, Khalid, Javaria Mona, O’Byrne, Sharon
Publicado 2019

656: POST-VACCINATION SYMPTOMS AFTER A THIRD DOSE OF SARS-COV-2 MRNA VACCINATION IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE

por Mujukian, Angela, Li, Dalin, Debbas, Philip, Banty, Andrea, Feldman, Edward J., Ha, Christina, Lee, Susie, Rabizadeh, Shervin, Stein, Theodore, Solomon, Theodore, Syal, Gaurav, Targan, Stephan R., Vasiliauskas, Eric A., Ziring, David, Bonthala, Nirupama, Hampton, Melissa, Pozdnyakova, Valeriya, Gu, Phillip, Ebinger, Joseph, Joung, Sandy, Figueiredo, Jane C., Merchant, Akil, Merin, Noah, Reckamp, Karen L., Appel, Keren, Kumar, Rashmi, Boland, Brigid, Charabaty, Aline, Chiorean, Michael V., Cohen, Erica, Flynn, Ann D., Valentine, John F., Ehrlich, Adam C., Fudman, David, Glover, Sarah C., Horizon, Arash A., Karayev, Dmitry, Kretzmann, Benjamin, Hou, Jason K., Hwang, Caroline, Lazarev, Mark, Lum, Donald, Fausel, Rebecca, Reddy, Swapna, McConnell, Ryan, Mattar, Mark, Metwally, Mark, Ostrov, Arthur, Nimisha, Parekh, Raffals, Laura H., Rubin, David T., Sheibani, Sarah, Siegel, Corey A., Wolf, Douglas C., Younes, Ziad H., Cheng, Susan, Braun, Jonathan G., Mcgovern, Dermot P.B., Melmed, Gil
Publicado 2022

653: PATIENTS WITH INFLAMMATORY BOWEL DISEASE HAVE IMPAIRED HUMORAL BUT PRESERVED CELLULAR RESPONSES TO SARS-COV-2 MRNA VACCINATION

por Li, Dalin, Xu, Alexander, Ebinger, Joseph, Debbas, Philip, Banty, Andrea, Feldman, Edward J., Ha, Christina, Lee, Susie, Rabizadeh, Shervin, Stein, Theodore, Solomon, Theodore, Syal, Gaurav, Targan, Stephan R., Vasiliauskas, Eric A., Ziring, David, Bonthala, Nirupama, Hampton, Melissa, Mujukian, Angela, Pozdnyakova, Valeriya, Gu, Phillip, Joung, Sandy, Appel, Keren, Kumar, Rashmi, Boland, Brigid S., Charabaty, Aline, Chiorean, Michael V., Cohen, Erica, Damas, Oriana M., Flynn, Ann D., Valentine, John F., Ehrlich, Adam C., Fudman, David, Glover, Sarah C., Horizon, Arash A., Karayev, Dmitry, Kretzmann, Benjamin, Hou, Jason K., Hwang, Caroline, Lazarev, Mark, Lum, Donald, Fausel, Rebecca, Reddy, Swapna, McConnell, Ryan, Mattar, Mark, Metwally, Mark, Ostrov, Arthur, Parekh, Nimisha K., Raffals, Laura H., Rubin, David T., Sheibani, Sarah, Siegel, Corey A., Wolf, Douglas C., Younes, Ziad H., Kaplan, Ian M., Prostko, John, Sobhani, Kimia, Merchant, Akil, Cheng, Susan, Braun, Jonathan G., Mcgovern, Dermot P.B., Melmed, Gil
Publicado 2022